raloxifene hydrochloride has been researched along with warfarin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allerheiligen, SR; Ghosh, A; Knadler, MP; Miller, JW; Skerjanec, A | 1 |
| Anderson, DW; Bhagwat, SS; Brady, H; Gayo-Fung, LM; Leisten, J; Lipps, SG; McKie, JA; O'Leary, E; Patnaik, N; Stein, B; Sutherland, MK | 1 |
| Bhagwat, SS; Brady, H; Doubleday, M; Gayo, L; Hickman, M; Jalluri, RK; Khammungkhune, S; Kois, A; McKie, JA; Mortensen, D; Richard, N; Sapienza, J; Shevlin, G; Stein, B; Sutherland, M | 1 |
| Cooperwood, JS; Khan, MO; Musa, MA; Rahman, T | 1 |
4 other study(ies) available for raloxifene hydrochloride and warfarin
| Article | Year |
|---|---|
Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.
Topics: Administration, Oral; Aged; Anticoagulants; Area Under Curve; Confidence Intervals; Drug Interactions; Estrogen Antagonists; Female; Humans; Middle Aged; Postmenopause; Prothrombin; Prothrombin Time; Raloxifene Hydrochloride; Stereoisomerism; Warfarin | 2001 |
Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
Topics: Administration, Oral; Animals; Body Weight; Bone Density; Bone Resorption; Cholesterol; Coumarins; Dose-Response Relationship, Drug; Female; Femur; Organ Size; Ovariectomy; Piperidines; Radiography; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Triglycerides; Uterus | 2003 |
Lead identification of a potent benzopyranone selective estrogen receptor modulator.
Topics: Animals; Binding Sites; Coumarins; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Interleukin-6; Molecular Structure; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Tumor Cells, Cultured | 2004 |
In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Raloxifene Hydrochloride; Receptors, Estrogen; Structure-Activity Relationship; Tamoxifen | 2011 |